$FONR
FONAR CORP Stock $fonr

$fonr Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-K Financial Statement

#000035501919000036 Filed on September 30, 2019

Income Statement

Concept	2019 Q2	2018 Q2	2018
Revenue	$22.48M	$21.04M	$81.52M
YoY Change	6.84%	0.72%	4.46%
Cost Of Revenue	$11.24M	$10.63M	$751.2K
YoY Change	5.74%	6.41%	-19.35%
Gross Profit	$11.24M	$10.41M	$80.76M
YoY Change	7.97%	-4.5%	4.75%
Gross Profit Margin	50.0%	49.48%	99.08%
Selling, General & Admin	$6.790M	$5.230M	$18.13M
YoY Change	29.83%	-22.97%	-6.61%
% of Gross Profit	60.41%	50.24%	22.44%
Research & Development	$440.0K	$500.0K	$1.756M
YoY Change	-12.0%	31.58%	18.58%
% of Gross Profit	3.91%	4.8%	2.17%
Depreciation & Amortization	$990.0K	$950.0K	$3.900M
YoY Change	4.21%	1.06%	10.37%
% of Gross Profit	8.81%	9.13%	4.83%
Operating Expenses	$7.240M	$5.720M	$19.88M
YoY Change	26.57%	-20.22%	-4.82%
Operating Profit	$4.000M	$4.690M	$60.88M
YoY Change	-14.71%	25.74%	8.3%
Interest Expense	$130.0K	$60.00K	-$160.1K
YoY Change	116.67%	-81.25%	-665.65%
% of Operating Profit	3.25%	1.28%	-0.26%
Other Income/Expense, Net	$0.00	$10.00K	-$4.271K
YoY Change	-100.0%		269.46%
Pretax Income	$4.140M	$4.760M	$19.78M
YoY Change	-13.03%	17.53%	2.41%
Income Tax	-$1.820M	-$6.590M	-$5.670M
% Of Pretax Income	-43.96%	-138.45%	-28.66%
Net Earnings	$4.580M	$9.840M	$21.23M
YoY Change	-53.46%	66.5%	8.21%
Net Earnings / Revenue	20.37%	46.77%	26.04%
Basic Earnings Per Share
Diluted Earnings Per Share	$667.6K	$1.447M	$3.118M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2018 Q2	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.00M	$19.60M	$19.60M
YoY Change	47.96%	94.06%	94.06%
Cash & Equivalents	$13.88M	$19.63M	$19.60M
Short-Term Investments	$15.10M
Other Short-Term Assets	$1.500M	$1.300M	$1.300M
YoY Change	15.38%	0.0%	0.0%
Inventory	$2.300M	$1.500M	$1.500M
Prepaid Expenses
Receivables	$51.70M	$44.60M	$44.60M
Other Receivables	$600.0K	$0.00	$0.00
Total Short-Term Assets	$85.09M	$67.06M	$67.10M
YoY Change	26.88%	25.56%	25.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.99M	$16.49M	$16.50M
YoY Change	2.99%	0.18%	0.0%
Goodwill	$3.985M	$3.985M
YoY Change	0.0%	1.48%
Intangibles	$4.756M	$5.602M
YoY Change	-15.1%	-15.69%
Long-Term Investments
YoY Change
Other Assets	$22.10M	$24.00M	$24.00M
YoY Change	-7.92%	31.15%	31.15%
Total Long-Term Assets	$48.47M	$51.24M	$51.20M
YoY Change	-5.39%	12.89%	12.78%
TOTAL ASSETS
Total Short-Term Assets	$85.09M	$67.06M	$67.10M
Total Long-Term Assets	$48.47M	$51.24M	$51.20M
Total Assets	$133.6M	$118.3M	$118.3M
YoY Change	12.9%	19.74%	19.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.861M	$1.300M	$1.300M
YoY Change	43.14%	-8.64%	-7.14%
Accrued Expenses	$7.000M	$7.400M	$7.400M
YoY Change	-5.41%	15.63%	15.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$313.6K	$344.4K	$0.00
YoY Change	-8.92%	-33.37%	-100.0%
Total Short-Term Liabilities	$14.09M	$14.57M	$14.60M
YoY Change	-3.27%	2.32%	2.82%
LONG-TERM LIABILITIES
Long-Term Debt	$300.0K	$300.0K	$300.0K
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$800.0K	$1.000M	$1.000M
YoY Change	-20.0%	11.11%	11.11%
Total Long-Term Liabilities	$1.358M	$1.510M	$1.300M
YoY Change	-10.04%	-6.61%	8.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.09M	$14.57M	$14.60M
Total Long-Term Liabilities	$1.358M	$1.510M	$1.300M
Total Liabilities	$15.45M	$16.08M	$19.60M
YoY Change	-3.91%	1.41%	-7.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$64.46M	-$79.77M
YoY Change	-19.2%	-21.02%
Common Stock	$181.1M	$179.1M
YoY Change	1.09%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$675.4K	-$675.0K
YoY Change	-200.06%	0.0%
Treasury Stock Shares
Shareholders Equity	$116.0M	$98.68M	$98.70M
YoY Change
Total Liabilities & Shareholders Equity	$133.6M	$118.3M	$118.3M
YoY Change	12.89%	19.79%	19.74%

Cashflow Statement

Concept	2019 Q2	2018 Q2	2018
OPERATING ACTIVITIES
Net Income	$4.580M	$9.840M	$21.23M
YoY Change	-53.46%	66.5%	8.21%
Depreciation, Depletion And Amortization	$990.0K	$950.0K	$3.900M
YoY Change	4.21%	1.06%	10.37%
Cash From Operating Activities	$6.320M	$6.140M	$18.74M
YoY Change	2.93%	-16.8%	11.5%
INVESTING ACTIVITIES
Capital Expenditures	-$320.0K	-$220.0K	-$2.778M
YoY Change	45.45%	-80.18%	-2.57%
Acquisitions
YoY Change
Other Investing Activities	-$90.00K	-$60.00K	-$60.00K
YoY Change	50.0%	-95.42%	-95.42%
Cash From Investing Activities	-$420.0K	-$280.0K	-$2.945M
YoY Change	50.0%	-88.43%	-31.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.790M	-1.640M	-$6.300M
YoY Change	9.15%	-36.19%	-42.08%
NET CHANGE
Cash From Operating Activities	6.320M	6.140M	$18.74M
Cash From Investing Activities	-420.0K	-280.0K	-$2.945M
Cash From Financing Activities	-1.790M	-1.640M	-$6.300M
Net Change In Cash	4.110M	4.220M	$9.494M
YoY Change	-2.61%	76.57%	489.22%
FREE CASH FLOW
Cash From Operating Activities	$6.320M	$6.140M	$18.74M
Capital Expenditures	-$320.0K	-$220.0K	-$2.778M
Free Cash Flow	$6.640M	$6.360M	$21.52M
YoY Change	4.4%	-25.09%	9.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	19633742	usd
CY2019Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	13882013	usd
CY2018Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	1431380	usd
CY2019Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	1798166	usd
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1349907	usd
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1512917	usd
CY2018Q2	us-gaap	Assets Current AssetsCurrent	67064542	usd
CY2019Q2	us-gaap	Assets Current AssetsCurrent	85088722	usd
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16492278	usd
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16985617	usd
CY2018Q2	us-gaap	Other Assets OtherAssets	1278061	usd
CY2019Q2	us-gaap	Other Assets OtherAssets	1207052	usd
CY2018Q2	us-gaap	Assets Net AssetsNet	118310945	usd
CY2019Q2	us-gaap	Assets Net AssetsNet	133560210	usd
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1300250	usd
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1861227	usd
CY2018Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8177995	usd
CY2019Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7577416	usd
CY2018Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4191930	usd
CY2019Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3812115	usd
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14566702	usd
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14089939	usd
CY2018Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1509772	usd
CY2019Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1358168	usd
CY2018Q2	us-gaap	Liabilities Liabilities	16076474	usd
CY2019Q2	us-gaap	Liabilities Liabilities	15448107	usd
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	179131780	usd
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	181086517	usd
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79772587	usd
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64455456	usd
CY2018Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2019Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2018Q2	us-gaap	Minority Interest MinorityInterest	3559182	usd
CY2019Q2	us-gaap	Minority Interest MinorityInterest	2155725	usd
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118310945	usd
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	133560210	usd
CY2017	us-gaap	Net Income Loss NetIncomeLoss	19620621	usd
CY2018	us-gaap	Net Income Loss NetIncomeLoss	21230802	usd
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15317131	usd
CY2018Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	1312299	usd
CY2019Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	1639777	usd
CY2018Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	119081	usd
CY2019Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	158389	usd
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40494731	usd
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43850187	usd
CY2018Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7004847	usd
CY2019Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7004847	usd
CY2018Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4835806	usd
CY2019Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4964199	usd
CY2018Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14138997	usd
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15113371	usd
CY2017	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	250000	usd
CY2018	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	185000	usd
CY2017	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	357235	usd
CY2018	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	265000	usd
CY2019	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	250000	usd
CY2018Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3262504	usd
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3011480	usd
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	752595	usd
CY2019Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	861345	usd
CY2018Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	4330769	usd
CY2019Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	4601801	usd
CY2018Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29280760	usd
CY2019Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25179894	usd
CY2018Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-6591749	usd
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-4242147	usd
CY2018Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-239011	usd
CY2019Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-243267	usd
CY2018Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3438087	usd
CY2019Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3897833	usd
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145029	usd
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145029	usd
CY2018Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2092403	usd
CY2019Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1671488	usd
CY2018Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	119262	usd
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	125567	usd
CY2018Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	125000	usd
CY2019Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	105000	usd
CY2018Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	681656	usd
CY2019Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	510540	usd
CY2017	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	19096080	usd
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	19684211	usd
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	22134192	usd
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3533564	usd
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3899851	usd
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3836491	usd
CY2017	FONR	Identifiable Assets IdentifiableAssets	98762566	usd
CY2018	FONR	Identifiable Assets IdentifiableAssets	118310945	usd
CY2019	FONR	Identifiable Assets IdentifiableAssets	130263901	usd
CY2017	FONR	Capital Expenditures CapitalExpenditures	3006314	usd
CY2018	FONR	Capital Expenditures CapitalExpenditures	2886777	usd
CY2019	FONR	Capital Expenditures CapitalExpenditures	3483849	usd
CY2017	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	8226718	usd
CY2018	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	8986882	usd
CY2019	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	9354864	usd
CY2017	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	34564	usd
CY2018	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	38728	usd
CY2019	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	40603	usd
CY2017	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	4273370	usd
CY2018	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	4913141	usd
CY2019	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	5947055	usd
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1480670	usd
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1755747	usd
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1812347	usd
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19407411	usd
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18125266	usd
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19261755	usd
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	58940506	usd
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	61831783	usd
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	65058695	usd
CY2017	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	19096080	usd
CY2018	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	19684211	usd
CY2019	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	22134192	usd
CY2017	us-gaap	Interest Expense InterestExpense	28299	usd
CY2018	us-gaap	Interest Expense InterestExpense	-160074	usd
CY2019	us-gaap	Interest Expense InterestExpense	-98636	usd
CY2017	us-gaap	Investment Income Net InvestmentIncomeNet	193141	usd
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	262569	usd
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	482573	usd
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19316364	usd
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19782435	usd
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22519194	usd
CY2017	us-gaap	Profit Loss ProfitLoss	23678798	usd
CY2018	us-gaap	Profit Loss ProfitLoss	25452185	usd
CY2019	us-gaap	Profit Loss ProfitLoss	20513674	usd
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4058177	usd
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4221383	usd
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5196543	usd
CY2017	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1116000	usd
CY2018	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1451000	usd
CY2019	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1557000	usd
CY2017	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-16171434	usd
CY2018	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-17896528	usd
CY2019	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts		usd
CY2017	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	20229166	usd
CY2018	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	21268885	usd
CY2019	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	24207536	usd
CY2018Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2019Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2018Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2019Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2018Q2	us-gaap	Goodwill Goodwill	3985397	usd
CY2019Q2	us-gaap	Goodwill Goodwill	3985397	usd
CY2018Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	239011	usd
CY2019Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	243267	usd
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	381860	usd
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	380470	usd
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	383929	usd
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	375561	usd
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2462025	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	38332	usd
CY2019Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	40530	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	306035	usd
CY2019Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	273112	usd
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4362434	usd
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5669750	usd
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2005520	usd
CY2017	FONR	Foreign Product Sales ForeignProductSales	55.9	pure
CY2018	FONR	Foreign Product Sales ForeignProductSales	41.5	pure
CY2019	FONR	Foreign Product Sales ForeignProductSales	5.3	pure
CY2017	us-gaap	Advertising Expense AdvertisingExpense	531000	usd
CY2018	us-gaap	Advertising Expense AdvertisingExpense	607000	usd
CY2019	us-gaap	Advertising Expense AdvertisingExpense	538000	usd
CY2019Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2019Q2	us-gaap	Cash Cash	11842000	usd
CY2017	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2018	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2019	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.277	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.035	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.56	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.185	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.026	pure
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.226	pure
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.286	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.089	pure
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4505000	usd
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4762000	usd
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4688000	usd
CY2018Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	20665597	usd
CY2019Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	16448054	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	115096	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	43767	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	313642	usd
CY2018Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	344367	usd
CY2019Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	313642	usd
CY2010Q3	FONR	Shares Registered Under Form S8 SharesRegisteredUnderFormS8	2000000	shares
CY2018Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	79000	usd
CY2019Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	68000	usd
CY2017	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.13	pure
CY2018	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2019	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.13	pure
CY2010Q2	FONR	Shares Reserved For2010 Stock Bonus Plan SharesReservedFor2010StockBonusPlan	2000000	shares
CY2018Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	22689011	usd
CY2019	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2015Q3	FONR	Ownership Interest After Reorganization For Health Management Corporation Of America Of Newly Expanded Hdm Percent OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent	0.458	pure
CY2019Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	20937747	usd
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5601656	usd
CY2019Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4755675	usd
CY2018Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	227543	usd
CY2019Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	92663	usd
CY2018Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-9213	usd
CY2019Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure		usd
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	82909953	usd
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	102234471	usd
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	60776307	usd
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	118112103	usd
CY2017	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2018	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2019	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2017	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	8987673	usd
CY2018	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	10256951	usd
CY2019	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	10789308	usd
CY2017	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.62	pure
CY2018	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.65	pure
CY2019	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.67	pure
CY2017	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2018	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2019	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
	FONR	Property Tax Abatement From Suffolk County Ida PropertyTaxAbatementFromSuffolkCountyIda	0.5	pure
	FONR	Property Tax Abatement PropertyTaxAbatement	440000	usd
CY2017	us-gaap	Interest Paid InterestPaid	162022	usd
CY2018	us-gaap	Interest Paid InterestPaid	44767	usd
CY2019	us-gaap	Interest Paid InterestPaid	165172	usd
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	739889	usd
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	345000	usd
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	304575	usd
CY2017	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	0.559	pure
CY2018	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	0.415	pure
CY2019	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	0.053	pure
CY2017	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	0.046	pure
CY2018	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	0.05	pure
CY2019	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	0.059	pure
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	771830	usd
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-416967	usd
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-787160	usd
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	70221	usd
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4552702	usd
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4132590	usd
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1685299	usd
CY2017	FONR	True Ups TrueUps	0.02	pure
CY2018	FONR	True Ups TrueUps	-0.018	pure
CY2019	FONR	True Ups TrueUps	-0.042	pure
CY2018Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1497429	usd
CY2019Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1054134	usd
CY2018Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	79129	usd
CY2019Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	67825	usd
CY2018Q2	us-gaap	Other Liabilities OtherLiabilities	737183	usd
CY2019Q2	us-gaap	Other Liabilities OtherLiabilities	749126	usd
CY2017	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2018	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2015Q3	FONR	Ownership Interest After Reorganization For Hdm Original Investors Of Newly Expanded Hdm Percent OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent	0.3	pure
CY2015Q3	FONR	Hmca Ownership Size Of Imperial Management Services Percent HmcaOwnershipSizeOfImperialManagementServicesPercent	0.242	pure
CY2012Q2	FONR	Contribution By Hmca Of All Its Assets And Liabilities To Imperial Management Services Llc Imperial ContributionByHmcaOfAllItsAssetsAndLiabilitiesToImperialManagementServicesLlcImperial	1	pure
CY2019Q2	FONR	Scanners With Management Agreements With Company Owned By Related Party ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty	3	pure
CY2019Q2	FONR	Scanners With Management With Company Located In New York State ScannersWithManagementWithCompanyLocatedInNewYorkState	19	pure
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24002453	usd
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26864570	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4655396	usd
CY2018Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	22450000	usd
CY2019Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	20694480	usd
CY2018Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	213781	usd
CY2019Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	192133	usd
CY2018Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	55514	usd
CY2019Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	65081	usd
CY2015Q3	FONR	Contribution Percent Of Its Assets By Imperial Which Were Utilized In Business Of Health Management Corporation Of America To Hdm ContributionPercentOfItsAssetsByImperialWhichWereUtilizedInBusinessOfHealthManagementCorporationOfAmericaToHdm	1	pure
CY2018Q4	dei	Entity Public Float EntityPublicFloat	130000000	usd
CY2019Q2	FONR	Management Agreements With Company Total Medical Practices ManagementAgreementsWithCompanyTotalMedicalPractices	22	pure
CY2015Q3	FONR	Percent Of Management Of Diagnostic Imaging Centers Business Segment Being Conducted By Hdm. PercentOfManagementOfDiagnosticImagingCentersBusinessSegmentBeingConductedByHdm.	1	pure
CY2017	FONR	Shares Issued Under2010 Stock Bonus Plan SharesIssuedUnder2010StockBonusPlan	193461	shares
CY2018	FONR	Shares Issued Under2010 Stock Bonus Plan SharesIssuedUnder2010StockBonusPlan	0	shares
CY2019	FONR	Shares Issued Under2010 Stock Bonus Plan SharesIssuedUnder2010StockBonusPlan	69971	shares
CY2019Q2	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	1671000	usd
CY2019Q2	FONR	Recorded Sales Tax Obligations Interest And Penalties RecordedSalesTaxObligationsInterestAndPenalties	1054000	usd
CY2017Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	7719358	usd
CY2018Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	6644504	usd
CY2019Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	5601656	usd
CY2017Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	155156	usd
CY2018Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	108829	usd
CY2019Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	128393	usd
CY2017Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff		usd
CY2018Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff		usd
CY2019Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff		usd
CY2017Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1230010	usd
CY2018Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1151677	usd
CY2019Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-974374	usd
CY2017Q2	FONR	Balance End Of Year Balance_EndOfYear	6644504	usd
CY2018Q2	FONR	Balance End Of Year Balance_EndOfYear	5601656	usd
CY2019Q2	FONR	Balance End Of Year Balance_EndOfYear	4755675	usd
CY2017	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	0.046	pure
CY2018	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	0.05	pure
CY2019	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	0.059	pure
CY2018Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-239011	usd
CY2019Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-243267	usd
CY2017	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	usd
CY2018	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	usd
CY2019	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	usd
CY2017	FONR	Total Facilities Owned Or Managed At Beginning Of Year TotalFacilitiesOwnedOrManagedAtBeginningOfYear	25	pure
CY2018	FONR	Total Facilities Owned Or Managed At Beginning Of Year TotalFacilitiesOwnedOrManagedAtBeginningOfYear	26	pure
CY2019	FONR	Total Facilities Owned Or Managed At Beginning Of Year TotalFacilitiesOwnedOrManagedAtBeginningOfYear	26	pure
CY2017	FONR	Managed Facilities Added Acquisition ManagedFacilitiesAddedAcquisition	1	pure
CY2018	FONR	Managed Facilities Added Acquisition ManagedFacilitiesAddedAcquisition	0	pure
CY2019	FONR	Managed Facilities Added Acquisition ManagedFacilitiesAddedAcquisition	0	pure
CY2017	FONR	Managed Facilities Added By Internal Development ManagedFacilitiesAddedByInternalDevelopment	0	pure
CY2018	FONR	Managed Facilities Added By Internal Development ManagedFacilitiesAddedByInternalDevelopment	0	pure
CY2019	FONR	Managed Facilities Added By Internal Development ManagedFacilitiesAddedByInternalDevelopment	0	pure
CY2017	FONR	Managed Facilities Closed During Year ManagedFacilitiesClosedDuringYear	0	pure
CY2018	FONR	Managed Facilities Closed During Year ManagedFacilitiesClosedDuringYear	0	pure
CY2019	FONR	Managed Facilities Closed During Year ManagedFacilitiesClosedDuringYear	0	pure
CY2017	FONR	Total Facilities Owned Or Managed At End Of Year TotalFacilitiesOwnedOrManagedAtEndOfYear	26	pure
CY2018	FONR	Total Facilities Owned Or Managed At End Of Year TotalFacilitiesOwnedOrManagedAtEndOfYear	26	pure
CY2019	FONR	Total Facilities Owned Or Managed At End Of Year TotalFacilitiesOwnedOrManagedAtEndOfYear	26	pure
CY2017Q2	FONR	Purchase Of Equity In Turnkey Services Of New York Llc PurchaseOfEquityInTurnkeyServicesOfNewYorkLlc	1	pure
CY2017	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	2397276	usd
CY2018	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1954744	usd
CY2019	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1990380	usd
CY2017	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2239302	usd
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1954745	usd
CY2017	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1680	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2017	FONR	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts	-206623	usd
CY2018	FONR	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts		usd
CY2019	FONR	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts		usd
CY2017	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-17498	usd
CY2018	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
CY2019	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-134880	usd
CY2017	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	87829	usd
CY2018	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
CY2019	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
CY2018Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	21863431	usd
CY2019Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	25709489	usd
CY2018Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	5535096	usd
CY2019Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	6500614	usd
CY2018Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	858195	usd
CY2019Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	798651	usd
CY2018Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	3813576	usd
CY2019Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	3736662	usd
CY2019Q3	FONR	Shares Of Common Stock To Employees And Consultants In Settlement Of Accrued Compensation Shares. SharesOfCommonStockToEmployeesAndConsultantsInSettlementOfAccruedCompensationShares.	89981	shares
CY2019Q3	FONR	Value Of Shares Issued In Settlement Of Liabilities Value ValueOfSharesIssuedInSettlementOfLiabilitiesValue	2000000	usd
CY2018Q2	FONR	Medical Receivable MedicalReceivable	13350772	usd
CY2019Q2	FONR	Medical Receivable MedicalReceivable	15728935	usd
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1156	usd
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4271	usd
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1065	usd
CY2017Q2	us-gaap	Shares Issued SharesIssued		shares
CY2018Q2	us-gaap	Shares Issued SharesIssued		shares
CY2016Q2	us-gaap	Shares Issued SharesIssued		shares
CY2019Q2	us-gaap	Shares Issued SharesIssued		shares
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	98675289	usd
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	115956378	usd
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-6981953	usd
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-6135000	usd
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-6600000	usd
CY2017	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	7333	usd
CY2018	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	7333	usd
CY2019	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	9213	usd
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1680	usd
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2017	FONR	Issuance Of Stock For Acquistion Shares IssuanceOfStockForAcquistionShares		shares
CY2018	FONR	Issuance Of Stock For Acquistion Shares IssuanceOfStockForAcquistionShares		shares
CY2019	FONR	Issuance Of Stock For Acquistion Shares IssuanceOfStockForAcquistionShares		shares
CY2017	FONR	Issuance Of Stock For Acquistion Value IssuanceOfStockForAcquistionValue	791210	usd
CY2018	FONR	Issuance Of Stock For Acquistion Value IssuanceOfStockForAcquistionValue		usd
CY2019	FONR	Issuance Of Stock For Acquistion Value IssuanceOfStockForAcquistionValue		usd
CY2017	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan		shares
CY2018	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan		shares
CY2019	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan		shares
CY2017	FONR	Stock Issued To Employees Under Stock Bonus Plans Value StockIssuedToEmployeesUnderStockBonusPlansValue	4636578	usd
CY2018	FONR	Stock Issued To Employees Under Stock Bonus Plans Value StockIssuedToEmployeesUnderStockBonusPlansValue		usd
CY2019	FONR	Stock Issued To Employees Under Stock Bonus Plans Value StockIssuedToEmployeesUnderStockBonusPlansValue	1954745	usd
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10139621	usd
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19633742	usd
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8528309	usd
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13882013	usd
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9780	usd
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1611312	usd
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9494121	usd
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5751729	usd
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10876869	usd
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6300151	usd
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6621512	usd
CY2017	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-6981953	usd
CY2018	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-6135000	usd
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-6600000	usd
CY2017	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	7333	usd
CY2018	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	7333	usd
CY2019	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	9213	usd
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-3990078	usd
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-172484	usd
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-30725	usd
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4319083	usd
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2945051	usd
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18578665	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18157	usd
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-155156	usd
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-108829	usd
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-128393	usd
CY2017	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-1312769	usd
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-58274	usd
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-2851158	usd
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-2777948	usd
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-3355456	usd
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16807264	usd
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18739323	usd
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19448448	usd
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8783	usd
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	16404	usd
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11943	usd
CY2017	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-410855	usd
CY2018	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	70311	usd
CY2019	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-59544	usd
CY2017	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3660895	usd
CY2018	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	525113	usd
CY2019	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-980394	usd
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	168733	usd
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-122967	usd
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	560977	usd
CY2017	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	254721	usd
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	15008	usd
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	329	usd
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-513507	usd
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1553	usd
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-79641	usd
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	450038	usd
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	192882	usd
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-366786	usd
CY2017	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-736061	usd
CY2018	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	649423	usd
CY2019	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-438472	usd
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	11511	usd
CY2018	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-894665	usd
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-12689	usd
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5899611	usd
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4328239	usd
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6134095	usd
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4969669	usd
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4919750	usd
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1755520	usd
CY2017	FONR	Provision For Bad Debts ProvisionForBadDebts	477577	usd
CY2018	FONR	Provision For Bad Debts ProvisionForBadDebts	-614680	usd
CY2019	FONR	Provision For Bad Debts ProvisionForBadDebts	-978730	usd
CY2017	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3533564	usd
CY2018	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3899851	usd
CY2019	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3836491	usd
CY2017	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	106600	shares
CY2019	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	69971	shares
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2239292	usd
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1954744	usd
CY2018Q2	FONR	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	448437	usd
CY2019Q2	FONR	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	448437	usd
CY2018Q2	FONR	Estimated Earnings EstimatedEarnings	309248	usd
CY2019Q2	FONR	Estimated Earnings EstimatedEarnings	1088675	usd
CY2018Q2	FONR	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	757685	usd
CY2019Q2	FONR	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	1537112	usd
CY2018Q2	FONR	Billings To Date BillingsToDate	671047	usd
CY2019Q2	FONR	Billings To Date BillingsToDate	1012002	usd
CY2018	FONR	Alternative Minimum Tax Credit AlternativeMinimumTaxCredit	-1200000	usd
CY2017	FONR	Tax Cuts And Jobs Act Rate Change TaxCutsAndJobsActRateChange	0	pure
CY2018	FONR	Tax Cuts And Jobs Act Rate Change TaxCutsAndJobsActRateChange	-0.269	pure
CY2019	FONR	Tax Cuts And Jobs Act Rate Change TaxCutsAndJobsActRateChange	0	pure
CY2018Q2	us-gaap	Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital	27600000	usd
CY2019Q2	us-gaap	Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital	2350000	usd
CY2019Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	65792000	usd
CY2019Q2	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus	243267	usd
CY2018Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	22689011	usd
CY2019Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	20937747	usd
CY2019Q2	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	250000	usd
CY2018Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	1200000	usd
CY2019Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4602000	usd
CY2018Q2	FONR	Revalued Deferred Tax Assets RevaluedDeferredTaxAssets	16000000	usd
CY2020Q2	FONR	First Installment FirstInstallment	600000	usd
CY2017	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments		usd
CY2018	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	-1200000	usd
CY2019	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments		usd
CY2019	FONR	Stipulation Agreement With Creditors StipulationAgreementWithCreditors	142299	usd
CY2019	FONR	Average Monthly Payment For Stipulation Agreements AverageMonthlyPaymentForStipulationAgreements	15859	usd
CY2018Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	86638	usd
CY2019Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	525110	usd
CY2017	FONR	Amt Credits AmtCredits	0	pure
CY2018	FONR	Amt Credits AmtCredits	-0.064	pure
CY2019	FONR	Amt Credits AmtCredits	0	pure
CY2019	dei	Entity Registrant Name EntityRegistrantName	FONAR CORP
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0000355019
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	FONR	Capital Stock And Options Disclosure Textblock CapitalStockAndOptionsDisclosureTextblock	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center">JUNE 30, 2019, 2018 and 2017</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">NOTE 8 - CAPITAL STOCK</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Common Stock</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Class B Common Stock</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146 of such shares outstanding at June 30, 2019, 2018 and 2017.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Class C Common Stock</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Class A Non-Voting Preferred Stock</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Stock Bonus Plans</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2019, 646,905 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2019, 2018 and 2017, 69,971, 0 and 193,461 shares were issued respectively.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0pt"></p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Options</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">The Company had stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Use of Estimates</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2019	FONR	Deferred Rent DeferredRent	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Deferred Rent</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Rent expense is recorded on the straight-line method based on the total minimum rent payments required over the term of the lease. The cumulative difference between the lease expense recorded under this method and the contractual lease payment terms is recorded as deferred rent.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2019	FONR	Revenue Recognition RevenueRecognition	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Revenue Recognition</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Revenue on sales contracts for scanners, included in “product sales” in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion method in accordance with FASB ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately three to six months.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Revenue from product sales (upgrades and supplies) is recognized upon shipment.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various medical providers (the "PCs"). As of June 30, 2019, the Company has twenty two management agreements of which three are with PC’s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (“the Related medical practices”) and nineteen are with PC’s, which are all located in the state of New York (“the New York PC’s”), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately $54,000 to $481,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts for estimated uncollectible fees, which is reflected in other operating expenses on the Statement of Operations. Revenue under lease contracts is recognized based upon contractual agreements for the leasing of medical equipment primarily under long term contracts to various unrelated PC’s. All fees are re-negotiable at the anniversary of the agreements and each year thereafter.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">On July 1, 2018, the Company adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board (“FASB”) and codified in the ASC as topic 606 (“ASC 606”). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company’s revenue recognition policies and significant judgments employed in the determination of revenue. </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">  </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">The Company applied the modified retrospective approach to all contracts when adopting ASC 606. As a result, at the adoption of ASC 606 the majority of what was previously classified as the provision for bad debts in the statement of operations is now reflected as implicit price concessions (as defined in ASC 606) and therefore included as a reduction to net operating revenues in 2019. For changes in credit issues not assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the statement of operations. For periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition standards that required it to be presented separately as a component of net operating revenues. Additionally, upon adoption of ASC 606 the allowance for doubtful accounts of approximately $22.7 million as of July 1, 2018 was reclassified as a component of net patient accounts receivable. Other than these changes in presentation on the condensed consolidated statement of operations and condensed consolidated balance sheet, the adoption of ASC 606 did not have a material impact on the consolidated results of operations for the year ended June 30, 2019 and is not expected to have a material impact on its consolidated results of operations on a prospective basis. </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Our revenues generally relate to net patient fees received from various payers and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt">The Company’s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2019, 2018 and 2017 are summarized in the following table.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2017</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Commercial Insurance/ Managed Care</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,218,656</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,729,514</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,904,892</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,172,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,233,078</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,274,436</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,790,025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,358,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,240,829</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,026,312</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,844,278</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,980,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,207,536</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,165,413</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,400,600</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(17,896,528</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(16,171,434</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,207,536</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,268,885</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,229,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"> </p>
CY2019	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Customer Advances</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Concentration of Credit Risk</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2019, the Company had cash on deposit of approximately $11,842,000 in excess of federally insured limits of $250,000.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Related Parties: Net revenues from related parties accounted for approximately 11%, 11% and 11% of the consolidated net revenues for the years ended June 30, 2019, 2018 and 2017, respectively. Net management fee receivables from the related party medical practices accounted for approximately 13%, 12% and 13% of the consolidated accounts receivable for the years ended June 30, 2019, 2018 and 2017, respectively.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">See Note 3 regarding the Company’s concentrations in the healthcare industry.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2019	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify">Reclassifications</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify">Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify"> </p>
CY2019	FONR	Estimated Useful Life In Years For Property And Equipment EstimatedUsefulLifeInYearsForPropertyAndEquipment	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">The estimated useful lives in years of property and equipment are generally as follows:</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Diagnostic equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5–13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Research, development and demonstration equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3-7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2-7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3-9</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2–10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; padding-left: 5.4pt">Building</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">28</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"> </p>
CY2019	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt">The Company’s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2019, 2018 and 2017 are summarized in the following table:</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2017</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Commercial Insurance/ Managed Care</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,218,656</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,729,514</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,904,892</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,172,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,233,078</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,274,436</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,790,025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,358,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,240,829</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,026,312</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,844,278</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,980,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,207,536</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,165,413</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,400,600</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(17,896,528</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(16,171,434</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,207,536</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,268,885</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,229,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"> </p>
CY2019	FONR	Export Product Sales ExportProductSales	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2017</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; padding-left: 5.4pt">United Arab Emirates</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">—  </td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">7.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">45.4</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">England</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Germany</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Puerto Rico</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.7</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.7</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">41.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55.9</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center">  </p>
CY2019	FONR	Export Service Revenues ExportServiceRevenues	<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:</p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2017</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; padding-left: 5.4pt">Puerto Rico</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1.6</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1.2</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Switzerland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Germany</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">England</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">United Arab Emirates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Greece</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Australia</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.0</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.9</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5.9</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4.6</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"> </p>
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	35416	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	38013	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	40820	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4323037	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3396273	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2778617	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5081636	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	22585152	usd
CY2019	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y37D
CY2019Q2	FONR	Common Stock Available Under Stock Bonus Plan CommonStockAvailableUnderStockBonusPlan	645905	shares
CY2017	FONR	Product Sales Net ProductSalesNet	1572148	usd
CY2018	FONR	Product Sales Net ProductSalesNet	602541	usd
CY2019	FONR	Product Sales Net ProductSalesNet	1751221	usd
CY2017	FONR	Service And Repair Fees Net ServiceAndRepairFeesNet	9537040	usd
CY2018	FONR	Service And Repair Fees Net ServiceAndRepairFeesNet	9124728	usd
CY2019	FONR	Service And Repair Fees Net ServiceAndRepairFeesNet	8152173	usd
CY2017	FONR	Patient Fee Revenue Net Of Contractual Allowances And Discounts PatientFeeRevenueNetOfContractualAllowancesAndDiscounts	36400600	usd
CY2018	FONR	Patient Fee Revenue Net Of Contractual Allowances And Discounts PatientFeeRevenueNetOfContractualAllowancesAndDiscounts	39165413	usd
CY2019	FONR	Patient Fee Revenue Net Of Contractual Allowances And Discounts PatientFeeRevenueNetOfContractualAllowancesAndDiscounts	24207536	usd
CY2017	FONR	Management And Other Fees Net ManagementAndOtherFeesNet	38361514	usd
CY2018	FONR	Management And Other Fees Net ManagementAndOtherFeesNet	41422958	usd
CY2019	FONR	Management And Other Fees Net ManagementAndOtherFeesNet	43617093	usd
CY2017	FONR	Costs Related To Product Sales CostsRelatedToProductSales	931501	usd
CY2018	FONR	Costs Related To Product Sales CostsRelatedToProductSales	751221	usd
CY2019	FONR	Costs Related To Product Sales CostsRelatedToProductSales	778734	usd
CY2017	FONR	Costs Related To Service And Repair Fees CostsRelatedToServiceAndRepairFees	2996736	usd
CY2018	FONR	Costs Related To Service And Repair Fees CostsRelatedToServiceAndRepairFees	3212527	usd
CY2019	FONR	Costs Related To Service And Repair Fees CostsRelatedToServiceAndRepairFees	3009097	usd
CY2017	FONR	Costs Related To Management And Other Fees CostsRelatedToManagementAndOtherFees	20828581	usd
CY2018	FONR	Costs Related To Management And Other Fees CostsRelatedToManagementAndOtherFees	22778202	usd
CY2019	FONR	Costs Related To Management And Other Fees CostsRelatedToManagementAndOtherFees	23419796	usd
CY2017Q1	FONR	Purchase Of Equity In Radwell Leasing Llcand Radwell Llc PurchaseOfEquityInRadwellLeasingLlcandRadwellLlc	1	pure
CY2019Q2	FONR	Allowance For Doubtful Accounts For Medical Receivablesnet AllowanceForDoubtfulAccountsForMedicalReceivablesnet	22727698	usd
CY2020Q2	FONR	Estimated Operating Lease Liabilities And Related Rightofuse Assets EstimatedOperatingLeaseLiabilitiesAndRelatedRightofuseAssets	18800000	usd
CY2019	FONR	Stoploss Umbrella Policy With3 Rd Paryinsurer To Limit Maximum Potential Liability For Individual Claims StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims	100000	usd
CY2017	FONR	Patient Fee Revenue Net PatientFeeRevenueNet	20229166	usd
CY2018	FONR	Patient Fee Revenue Net PatientFeeRevenueNet	21268885	usd
CY2019	FONR	Patient Fee Revenue Net PatientFeeRevenueNet	24207536	usd
CY2018Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	40530	usd
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2350193	usd
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2017	us-gaap	Revenues Revenues	78036586	usd
CY2018	us-gaap	Revenues Revenues	81515994	usd
CY2019	us-gaap	Revenues Revenues	87192887	usd
CY2017	FONR	Intersegment Net Revenues IntersegmentNetRevenues	1200000	usd
CY2018	FONR	Intersegment Net Revenues IntersegmentNetRevenues	901250	usd
CY2019	FONR	Intersegment Net Revenues IntersegmentNetRevenues	907084	usd
CY2019	dei	Entity File Number EntityFileNumber	0-10248
CY2017	FONR	Shipping And Handling Expense ShippingAndHandlingExpense	8224	usd
CY2018	FONR	Shipping And Handling Expense ShippingAndHandlingExpense	9370	usd
CY2019	FONR	Shipping And Handling Expense ShippingAndHandlingExpense	13695	usd
CY2018Q2	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2019Q2	us-gaap	Short Term Investments ShortTermInvestments	15094816	usd
CY2019Q1	us-gaap	Short Term Investments ShortTermInvestments	15000	usd
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	-15094816	usd
CY2019Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3902000	usd
CY2019	FONR	Length Of Straight Line Basis For Amortization Of Customer Relationships LengthOfStraightLineBasisForAmortizationOfCustomerRelationships	P20Y
CY2018Q2	FONR	Income Taxes Receivable Current IncomeTaxesReceivableCurrent		usd
CY2019Q2	FONR	Income Taxes Receivable Current IncomeTaxesReceivableCurrent	600000	usd
CY2018Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	1200000	usd
CY2019Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	600000	usd
CY2018	FONR	Fonar Corporation Statutory Income Tax Rate FonarCorporationStatutoryIncomeTaxRate	0.277	pure
CY2019	FONR	Fonar Corporation Statutory Income Tax Rate FonarCorporationStatutoryIncomeTaxRate	0.21	pure
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.082	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.068	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.058	pure
CY2017	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	2397276	usd
CY2018	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances		usd
CY2019	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances		usd
CY2017	FONR	Subtotal Current Federal And State SubtotalCurrentFederalAndState	607235	usd
CY2018	FONR	Subtotal Current Federal And State SubtotalCurrentFederalAndState	450000	usd
CY2019	FONR	Subtotal Current Federal And State SubtotalCurrentFederalAndState	250000	usd
CY2017	FONR	Subtotal Deferred Federal And State Taxes SubtotalDeferredFederalAndStateTaxes	-4969669	usd
CY2018	FONR	Subtotal Deferred Federal And State Taxes SubtotalDeferredFederalAndStateTaxes	-6119750	usd
CY2019	FONR	Subtotal Deferred Federal And State Taxes SubtotalDeferredFederalAndStateTaxes	1755520	usd
CY2019Q1	FONR	Cash And Cash Equivalents CashAndCashEquivalents	9780	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000355019-19-000036-index-headers.html	Edgar Link	pending
0000355019-19-000036-index.html	Edgar Link	pending
0000355019-19-000036.txt	Edgar Link	pending
0000355019-19-000036-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fonr-20180630_cal.xml	Edgar Link	unprocessable
fonar-logo.jpg	Edgar Link	pending
fonar_10k.htm	Edgar Link	pending
fonar_exhibit-21.htm	Edgar Link	pending
fonar_exhibit-23.htm	Edgar Link	pending
fonar_exhibit-31.htm	Edgar Link	pending
fonar_exhibit-32.htm	Edgar Link	pending
fonr-20180630.xsd	Edgar Link	pending
fonr-performance_graph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
fonr-20180630_pre.xml	Edgar Link	unprocessable
fonr-20180630_lab.xml	Edgar Link	unprocessable
fonr-20180630.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fonr-20180630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FONR
FONAR CORP Stock $fonr

2019 Q2 Form 10-K Financial Statement

#000035501919000036 Filed on September 30, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR FONAR CORP Stock $fonr

2019 Q2 Form 10-K Financial Statement

#000035501919000036 Filed on September 30, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR
FONAR CORP Stock $fonr